Table 5.
Associations of SF‐SIS With Clinical and Demographic Outcome Predictors—Acute Trial Data Set
| Variable | Coefficient (95% CI) | ||
|---|---|---|---|
| SIS‐16 | SF‐SIS | SF‐SIS (Pilot) | |
| Age | −0.777 (−0.851 to −0.702) | −0.454 (−0.523 to −0.386) | −0.456 (−0.521 to −0.392) |
| Baseline NIHSS | −2.619 (−2.79 to −2.45) | −1.924 (−2.082 to −1.766) | −1.655 (−1.807 to −1.504) |
| SBP | −0.105 (−0.14 to −0.069) | −0.056 (−0.090 to −0.023) | −0.052 (−0.083 to −0.021) |
| Glucose | −1.223 (−1.56 to 0.88) | −0.619 (−0.930 to −0.308) | −0.596 (−0.890 to −0.301) |
| Sex (female=1) | −8.85 (−10.78 to −6.92) | −5.398 (−7.149 to −3.647) | −5.346 (−6.992 to −3.698) |
| Use of tPA (yes=1) | 4.287 (2.26 to 6.32) | 2.163 (0.333 to 3.993) | 2.140 (0.418 to 3.862) |
| AF (yes=1) | −11.17 (−13.5 to −8.84) | −6.814 (−8.922 to −4.706) | −6.663 (−8.647 to −4.678) |
| Prior stroke (yes=1) | −4.16 (−6.65 to −1.67) | −4.427 (−6.628 to −2.225) | −4.952 (−7.022 to −2.883) |
AF indicates atrial fibrillation; NIHSS, National Institutes of Health Stroke Scale; SBP, systolic blood pressure; SF‐SIS (pilot), short form of Stroke Impact Scale derived in initial pilot work; SF‐SIS, short form of Stroke Impact Scale derived from VISTA resource; tPA, tissue plasminogen activator (thrombolysis).